Primary Prevention Benefits and Risks of oral Anticoagulation with Dabigatran or Warfarin

被引：0
|
作者：
Diener, H. C.
机构：
来源：
AKTUELLE NEUROLOGIE | 2015年 / 42卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E53 / E53
页数：1
相关论文
共 50 条
  • [21] Primary Prevention Predictors for Stroke Risk with oral Anticoagulation
    Albertsen, I. E.
    Rasmussen, L. H.
    Overvad, T. F.
    AKTUELLE NEUROLOGIE, 2013, 40 (09) : E43 - E43
  • [22] Maximizing Benefits and Minimizing Risks in the Primary Prevention of Schizophrenia
    DeVylder, Jordan
    SOCIAL WORK, 2014, 59 (04) : 363 - 365
  • [23] Thromboembolic diseases: Oral anticoagulation with dabigatran etexilate
    Wedekind, Silke
    INTERNIST, 2008, 49 (01): : 131 - 132
  • [24] Genetic modulation of oral anticoagulation with warfarin
    Margaglione, M
    Colaizzo, D
    D'Andrea, G
    Brancaccio, V
    Clampa, A
    Grandone, E
    Di Minno, G
    THROMBOSIS AND HAEMOSTASIS, 2000, 84 (05) : 775 - 778
  • [25] Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
    Winkle, Roger A.
    Mead, R. Hardwin
    Engel, Gregory
    Kong, Melissa H.
    Patrawala, Rob A.
    EUROPACE, 2014, 16 (10): : 1443 - 1449
  • [26] Equivalent thrombotic risk with Warfarin, Dabigatran, or Enoxaparin after failure of initial direct oral anticoagulation (DOAC) therapy
    Shyu, Margaret
    Liu, Angela
    Srikureja, Anya
    Gregorian, Alison
    Srisuwananukorn, Andrew
    Tremblay, Douglas
    Naymagon, Leonard
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (05) : 871 - 876
  • [27] Risks and benefits of warfarin plus aspirin
    Nature Clinical Practice Cardiovascular Medicine, 2004, 1 (1): : 7 - 7
  • [28] Effects on warfarin dosage requirements after anticoagulation therapy with dabigatran.
    Brubaker, Beth H.
    Lucas, Kristy
    Broce, Mike
    PHARMACOTHERAPY, 2012, 32 (10): : E307 - E307
  • [29] Perception of the Risk of Stroke and the Risks and Benefits of Oral Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation: A Cross-Sectional Study
    Hijazi, Mohammad
    Aljohani, Sami
    Alqahtani, Fahad
    Chaker, Zakeih
    Al Hajji, Muhammad
    Al Hallak, Ahmad
    Alkhouli, Mohamad
    MAYO CLINIC PROCEEDINGS, 2019, 94 (06) : 1015 - 1023
  • [30] Anticoagulation: Risks and benefits in atrial fibrillation
    Fiore, LD
    GERIATRICS, 1996, 51 (06) : 22 - &
12345